About NuGen MD
NuGen MD is a publicly listed company based in Toronto (Canada) founded in 2016. Developer of needle-free drug delivery system. NuGen MD offers products and services including Needle-free Drug Delivery Device, Product Tutorial, and Infographic. Its focus areas include Life Sciences, Drug Delivery and Safe Syringes.
Company details
NuGen MD was founded in 2016 in Toronto, Canada, within the medical device sector. Needle-free systems using spring-loaded mechanisms are developed by the company to enable self-administration of drugs and vaccines. Applications include treatments for diabetes, dental anesthesia, cosmetic procedures, veterinary care, and additional medical uses. Operations focus on innovation in painless delivery methods for diverse healthcare needs.
- Headquarters Toronto, Canada
- Stage Public
- SectorsHealthcare
- Phone•••• ••••
- Website nugenmd.com
- Social LinkedIn X Facebook
- Legal Name Nugen Medical Devices Inc
- Annual Revenue$188.4 K (USD)-74.46as on Dec 31, 2025
- Net Profit-$5.72 M (USD)-49.76as on Dec 31, 2025
- EBITDA-$2.58 M (USD)21.77as on Dec 31, 2025
- Latest Funding Round$125K (USD), Post-IPO
Dec 2022
Products & Services of NuGen MD
NuGen MD offers a comprehensive portfolio of products and services, including Needle-free Drug Delivery Device, Product Tutorial, and Infographic.
Enables drug administration without needles for safer patient use.
Guides users on operating needle-free delivery systems effectively.
Provides visual details on needle-free technologies for diabetes care.
Funding Insights of NuGen MD
- Total Rounds 2
- Last Round Post-IPO — $125,000
- First Round $411,800
(Jul 2022)
All 2 funding rounds of NuGen MD with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec 2022 | $125,000 | Post-IPO | – | – | – |
| Jul 2022 | $411,800 | Post-IPO | – | – | – |
IPO & Listings of NuGen MD
NuGen MD is a publicly listed company on the TSXV with ticker symbol NGMD in Canada, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date12 Nov 2021
- Listed onTSX-V: NGMD
- Listed entityNuGen Medical Devices Inc
- Exchange sectorHealth technology
- ISINCA67054F1009
- Share price0.03 CAD (+25% on the day) · 2026-05-11
- Market capitalisation5,228,828.00 CAD
- EPS (diluted, trailing year)-0.03 CAD
- Volume (last session)200,000
- Analyst consensusNo rating
Financials of NuGen MD
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | 257,950 CAD | -7.8M CAD | -3.5M CAD |
| 2024 | 1.0M CAD | -5.2M CAD | -4.5M CAD |
| 2023 | 331,400 CAD | -9.4M CAD | -7.4M CAD |
| 2022 | 152,360 CAD | -5.6M CAD | -4.1M CAD |
| 2021 | 137,650 CAD | -7.1M CAD | -6.9M CAD |
Detailed financial statements for NuGen MD
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of NuGen MD
4 dated milestones of NuGen MD across 6 years, from founding to its latest funding, stage changes and deals.
- Founded NuGen MD is founded.
- IPO Lists on the stock exchange (IPO).
- Funding First funding round of $412K.
- Funding Latest funding round, Post-IPO, of $125K.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Nugen Md
Complete news archive for NuGen MD
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about NuGen MD
NuGen MD was founded in 2016 and raised its 1st funding round 6 years after it was founded.
NuGen MD is headquartered in Toronto, Canada. It is registered at Toronto, Ontario, Canada.
Annual revenue of NuGen MD is $188.4K as on Dec 31, 2025.
NuGen MD was founded in 2016 in Toronto, Canada, within the medical device sector. Needle-free systems using spring-loaded mechanisms are developed by the company to enable self-administration of drugs and vaccines. Applications include treatments for diabetes, dental anesthesia, cosmetic procedures, veterinary care, and additional medical uses. Operations focus on innovation in painless delivery methods for diverse healthcare needs.
NuGen MD offers Needle-free Drug Delivery Device, Product Tutorial, and Infographic.
Yes, NuGen MD is publicly traded on TSXV under the ticker symbol NGMD.